| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/09/2003 | EP1324923A2 Container tracking system |
| 07/09/2003 | EP1324780A2 Cardiac arrhythmia treatment methods |
| 07/09/2003 | EP1324778A2 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 07/09/2003 | EP1324776A2 Reduced-viscosity concentrated protein formulations |
| 07/09/2003 | EP1324771A2 Therapeutic antibodies |
| 07/09/2003 | EP1324767A2 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 07/09/2003 | EP1324766A2 Methods and compositions for the treatment of peripheral artery disease |
| 07/09/2003 | EP1324765A1 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 07/09/2003 | EP1324764A2 Method for inducing onset of the reproductive cycle of female breeding animals |
| 07/09/2003 | EP1324763A1 Stat3 agonists and antagonists and therapeutic uses thereof |
| 07/09/2003 | EP1324652A2 Transgenic drosophila melanogaster expressing beta amyloid |
| 07/09/2003 | EP1224212B1 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof |
| 07/09/2003 | EP1173151B1 Dry, mouldable drug formulation |
| 07/09/2003 | EP1143929B1 BIODEGRADABLE pH/THERMOSENSITIVE HYDROGELS FOR SUSTAINED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS |
| 07/09/2003 | EP1112081A4 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS |
| 07/09/2003 | EP1080109B1 Method for purification of borrelia lipoprotein ospa |
| 07/09/2003 | EP1071752B1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 07/09/2003 | EP1040096B1 Neuroprotective agents |
| 07/09/2003 | EP1035862B1 Cyclosporin-containing microemulsion preconcentrate composition |
| 07/09/2003 | EP1028706B1 Buffered drug formulations for transdermal electrotransport delivery |
| 07/09/2003 | EP0988316A4 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 07/09/2003 | EP0988056B1 Tissue factor methods and compositions for coagulation and tumor treatment |
| 07/09/2003 | EP0964690B1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 07/09/2003 | EP0920443B1 Activated peptides and conjugates |
| 07/09/2003 | EP0914340B1 hGH-RH(1-29)NH2 ANALOGUES HAVING ANTAGONISTIC ACTIVITY |
| 07/09/2003 | EP0894004B1 Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma |
| 07/09/2003 | EP0788307B1 Oligonucleotide modulation of the expression of multidrug resistance-associated protein |
| 07/09/2003 | EP0717631B1 Immunomodulating compositions from bile |
| 07/09/2003 | EP0686260B1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 07/09/2003 | EP0686194B1 Harp family growth factors, preparation methods therefor and uses thereof |
| 07/09/2003 | EP0619738B1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 07/09/2003 | EP0573576B2 Compositions for topical administration of pharmaceutically active agents |
| 07/09/2003 | EP0511308B2 Chimeric immunoglobulin for cd4 receptors |
| 07/09/2003 | CN1429273A Protection against environmental toxicity through manipulation of processing of messenger RNA precursors |
| 07/09/2003 | CN1429268A Novel deoxyribonucleside kinase enzyme multi-substrate variants |
| 07/09/2003 | CN1429119A Method for preparation of polymeric micelle via separation of block copolymer |
| 07/09/2003 | CN1429117A Pharmaceutical composition comprising factor VIIa and factor XIII |
| 07/09/2003 | CN1429116A Pharmaceutical composition |
| 07/09/2003 | CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 07/09/2003 | CN1429106A Methods for inhibiting angiogenesis and tumor growth |
| 07/09/2003 | CN1429073A A gene therapy system and method using alpha-MSH and its derivatives |
| 07/09/2003 | CN1428426A Programmed cell death induction molecule II |
| 07/09/2003 | CN1428352A Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 07/09/2003 | CN1428347A Clone, expression and biological activity of stingray tumor suppressor gene |
| 07/09/2003 | CN1428173A Recombinant hirudin oral enteric soluble slowly-releasing preparation |
| 07/09/2003 | CN1428144A Method for preparing mass micro-capsule |
| 07/09/2003 | CN1113964C High-efficiency expression of artificially synthetic interferon alpha-2b gene in colibacillus |
| 07/09/2003 | CN1113963C Preparation and application of rhBTR gene and gene probe |
| 07/09/2003 | CN1113895C Growth hormone secretagogues |
| 07/09/2003 | CN1113894C Process for preparing intermediates of inhibitors of enkephalinase and angiotensin coverting enzyme and intermediates thereof |
| 07/09/2003 | CN1113669C Method for treating endothelial injury |
| 07/09/2003 | CN1113656C Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
| 07/09/2003 | CN1113655C Oxygen-reduced solidifying factor VIII aqueous solution |
| 07/09/2003 | CN1113653C Use of leukotriene B4 or its analogues as antiviral and antineoplastic agents |
| 07/09/2003 | CN1113599C Antimicrobial treatment method for herpes simplex virus and other infectious diseases |
| 07/08/2003 | US6590140 Transgenic plant which expresses a polypeptide comprising given amino acid sequence; iron uptake; can be used to remove pollutants from soil or as nutritional supplements to treat iron- or zinc-deficiency |
| 07/08/2003 | US6590090 Isolated DNA comprising nucleotide sequence coding for a protein of given amino acid sequence; useful as prophylactic or therapeutic agents for cancer, viral/bacterial infections, hepatitis, nephritis, bone disease, atherosclerosis or pain |
| 07/08/2003 | US6590089 Isolated cDNA encoding a protein of given amino acid sequence; use in diagnosis and treatment of cell proliferative disorders (cancer) and autoimmune disorders |
| 07/08/2003 | US6590086 Mutants of the Rb and p53 genes and uses thereof |
| 07/08/2003 | US6590079 Vitazin antibody; treating angiogenesis or restenosis |
| 07/08/2003 | US6590077 Polypeptide, of given sequence, which stimulates increased growth or altered cell morphology in cells; use in diagnosis, treatment, and prevention of autoimmune/inflammatory, cell proliferative, and vesicle trafficking disorders |
| 07/08/2003 | US6590076 Isolated polypeptide, of given sequence, comprising at least an immunogenic portion of a tumor antigen; may be used to generate antibodies |
| 07/08/2003 | US6590075 Secreted protein HODAZ50 |
| 07/08/2003 | US6590074 Prosaposin receptor |
| 07/08/2003 | US6590073 Providing solution comprising an echinocandin compound, an aldehyde impurity and solvent; concentrating by nanofiltration to form concentrate; adding derivatizing agent to react with aldehyde; adjusting pH, adding acid or metal salt; cooling |
| 07/08/2003 | US6590071 Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 07/08/2003 | US6589987 Dithiocarbamate, particularly tetraethylthiuram disulfide strongly inhibits the growth of cancer cells of a variety of cell types. Such inhibitory effect is enhanced by heavy metal ions such as copper ions, cytokines and ceruloplasmin and |
| 07/08/2003 | US6589940 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 07/08/2003 | US6589938 Cardiovascular disorders |
| 07/08/2003 | US6589937 Peptides and nootropic agent |
| 07/08/2003 | US6589936 Therapeutically effective amounts of recombinant troponin C, I or T subunits for the treatment of diseases or disorders involving abnormal angiogenesis. |
| 07/08/2003 | US6589935 Insulin receptor tyrosine kinase substrate |
| 07/08/2003 | US6589933 Chemokine binding protein 5(type-2 CBP) encoded by poxviruses and having amino acid sequence homology with the Shope fibroma virus T1 family of proteins against disease syndromes associated with acute or chronic dysregulated inflammatory |
| 07/08/2003 | US6589782 VEGF (Vascular Endothelial Growth Factor); adenovirus vector; Use in treating cardiovascular disorders, enhancing the neovascularization of diseased blood vessels and enhancing drug delivery via improved vascular permeability |
| 07/08/2003 | US6589770 Keratinocyte derived protease |
| 07/08/2003 | US6589767 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 07/08/2003 | US6589764 IL-18 receptor fusion proteins |
| 07/08/2003 | US6589759 Thrombopoietin as thrombopoiesis stimulating factor and S-nitrosoglutathione as nitiric oxide donor; use for treating and preventing blood disorders |
| 07/08/2003 | US6589750 Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives |
| 07/08/2003 | US6589745 CIF130 inhibits cell cycle progression |
| 07/08/2003 | US6589736 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 07/08/2003 | US6589728 Methods for isolation and activation of, and control of differentiation from, stem and progenitor cells |
| 07/08/2003 | US6589725 Adding candidate drug to a cell comprising a recombinant nucleic acid encoding the protein and determining its effect on cell proliferation and viability; drug screening |
| 07/08/2003 | US6589576 Includes xanthan gum which improves tolerance (e.g. less gastrointestinal symptoms such as emesis, stool patterns and gas) |
| 07/08/2003 | US6589560 Stable glassy state powder formulations |
| 07/08/2003 | US6589559 Nasally administrable compositions |
| 07/08/2003 | US6589549 Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles |
| 07/08/2003 | US6589548 Controlled drug delivery system using the conjugation of drug to biodegradable polyester |
| 07/08/2003 | US6589540 Cosmetic composition for skin care containing retinol and epidermal growth factor |
| 07/08/2003 | US6589536 Soft gelatin capsule manufacture |
| 07/08/2003 | US6589534 Hepatitis B virus binding proteins and uses thereof |
| 07/08/2003 | US6589532 Papilloma viruses, means for the detection thereof and therapy for diseases caused thereby |
| 07/08/2003 | US6589531 Recombinant yellow fever virus and method of use thereof |
| 07/08/2003 | US6589530 Hepatitis B surface antigen vaccine |
| 07/08/2003 | US6589529 Recombinant fusion proteins as immunogens; VP6 protein or carboxy- terminal fragment |
| 07/08/2003 | US6589527 Using binding substance to connect antibodies to target that they normally have no functional specificity for |
| 07/08/2003 | US6589503 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 07/08/2003 | CA2197139C A drug for the treatment of cancer |
| 07/08/2003 | CA2141203C Amylin muteins |
| 07/08/2003 | CA2133646C Stem cell proliferation factor |